Sonavex raises $3M for ultrasound blood-clot detector

Baltimore-based Sonavex is developing a device that uses ultrasound to screen for blood clots post-surgery.

Johns Hopkins spinout Sonavex reeled in $3 million, including $2.2 million from the first close of its Series A round, which will drive the commercialization of the company’s ultrasound device that detects blood clots in patients after surgery.

While ultrasound is useful for monitoring blood flow, sonographers must be trained to interpret the images. Sonavex’s EchoSure technology is a doppler ultrasound system that automatically detects blood flow loss, making it possible for non-sonographers to monitor blood flow. It would be useful for the monitoring of patients who have undergone procedures that involve surgically connecting arteries and veins, the company said.

Catching postoperative clots early allows physicians to intervene quickly to prevent vessel blockage and surgical failure.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

RELATED: GE Healthcare, Endra partner to improve point-of-care ultrasound for fatty liver

“Our ultrasound technology offers a game-changing solution to a catastrophic problem for patients,” said Sonavex Chief Medical Officer Devin O’Brien Coon, M.D., in a statement. “For decades, surgeons have sought a reliable way to detect early thrombosis after surgery and we are eager to begin using EchoSure in the clinic.”

The funding comprises $2.2 million in equity and another $750,000 in a Small Business Innovation Research grant from the National Science Foundation, according to the statement. In addition to bankrolling the commercialization of the EchoSure technology, the funds will support the development of Sonavex’s pipeline of perioperative ultrasound solutions, the company said.

Grey Sky Venture Partners led the financing, while CRCM Venture Capital, TEDCO and the Abell Foundation also participated.


Suggested Articles

The Rady Children’s Institute for Genomic Medicine tapped Deloitte to help develop a network of flying drones to deliver genetic testing specimens.

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart.

The respiratory care company Vyaire Medical has brought on a new CEO, Gaurav Agarwal, following a year of new product launches.